Post-shock treatment in a subcutaneous device

• US 9,144,683 B2
• Filed: 10/30/2006
• Issued: 09/29/2015
• Est. Priority Date: 09/18/2000
• Status: Expired due to Term

• Current Assignee: Cameron Incorporated (Schlumberger NV)
• Original Assignee: Cameron Incorporated (Schlumberger NV)
• Inventors: Bardy, Gust H., Cappato, Riccardo, Rissmann, William J.
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): D ABREU, MICHAEL JOSEPH
• Application Number:
  US11/554,185
• Publication Number:
  US 20070055314A1
• Time in Patent Office: 3,256 Days
• Field of Search: 607/2, 607/4, 607/5, 607/9, 607/36, 607/116
• US Class Current: 1/1
• CPC Class Codes: A61N 1/362 Heart stimulators heart defibrillators A61N1/39
• CPC Class Codes: A61N 1/375 Constructional arrangements, e.g. casings
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators
• CPC Class Codes: A61N 1/3906 characterised by the form of the shockwave
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/39622 Pacing therapy
• CPC Class Codes: A61N 1/3968 Constructional arrangements, e.g. casings A61N1/375 takes precedence
• CPC Class Codes: A61N 1/3975 Power supply A61N1/378 takes precedence

Abstract

A power supply for an implantable cardioverter-defibrillator for subcutaneous positioning between the third rib and the twelfth rib and using a lead system that does not directly contact a patient'"'"'s heart or reside in the intrathoracic blood vessels and for providing anti-bradycardia pacing energy to the heart, comprising a capacitor subsystem for storing the anti-bradycardia pacing energy for delivery to the patient'"'"'s heart; and a battery subsystem electrically coupled to the capacitor subsystem for providing the anti-bradycardia pacing energy to the capacitor subsystem.

Claims

1. A method of medically treating a person comprising:

using an implantable cardiac stimulus system having a canister with circuitry for the system contained therein and a subcutaneous lead for coupling to the canister, delivering a defibrillation stimulus to the person; and

,

during a time period following a delivery of defibrillation stimulus;

a) utilizing electronic signals generated from the heart of the person to detect QRS waves and to calculate a ventricular rate and determining whether a that the ventricular rate of the person is below a predetermined level; and

b) applying a series of electrical pacing pulses to the person using the implantable cardiac stimulus system, wherein the pacing pulses are biphasic with initial peak voltages of 20 volts for the positive phase and −

20 volts for the negative phase, in response to finding the ventricular rate for the person is below the predetermined level; and

wherein the series of pacing pulses is applied between a first electrode disposed subcutaneously as part of the subcutaneous lead, and a second electrode disposed on the canister;

wherein the canister is disposed at the left mid-clavicular line approximately at the level of the inframammary crease, and the subcutaneous lead assembly extends around the thorax to the posterior axillary line with a distal end lateral to the left scapula;

wherein the implantable cardiac stimulus system only includes electrodes which do not directly contact a patient'"'"'s heart or reside in the intrathoracic blood vessels; and

wherein the predetermined level is in the range of approximately 20 to approximately 40 beats per minute.

2. The method of claim 1, wherein the series of pacing pulses is applied at a rate of approximately 50 stimuli/minute.

3. The method of claim 1, wherein the series of pacing pulses is applied at a rate in the range of approximately 40 to approximately 120 stimuli/minute.

4. The method of claim 1, wherein the canister is disposed at about the level of the inframammary crease of the person and over the person'"'"'s ribs.

5. The method of claim 1, wherein:

the series of pacing pulses is applied at a rate in the range of approximately 40 to approximately 120 stimuli/minute; and

the canister is disposed at about the level of the inframammary crease of the person and over the person'"'"'s ribs.

6. The method of claim 1, wherein the lead includes an anchoring element at a distal portion thereof.

7. The method of claim 1, wherein the lead includes an anchoring screw at a distal portion thereof.

8. The method of claim 1, wherein the lead includes an anchoring tine at a distal portion thereof.

9. The method of claim 1, wherein the pacing pulses have a tilt in the range of 10%-90%.

10. The method of claim 1, wherein the pacing pulses have a tilt of about 50%.

11. The method of claim 1 wherein the canister is disposed at the level of the left inframammary crease.

12. A method of medically treating a person comprising:

using an implantable cardiac stimulus system having a canister with circuitry for the system contained therein and a subcutaneous lead for coupling to the canister, delivering a defibrillation stimulus to the person; and

,

during a time period following a delivery of defibrillation stimulus;

a) utilizing electronic signals generated from the heart of the person to detect QRS waves and to calculate a ventricular rate and determining that the ventricular rate of the person is below a predetermined level; and

b) applying a series of electrical pacing pulses to the person using the implantable cardiac stimulus system, wherein the pacing pulses are biphasic with initial peak voltages of 20 volts for the positive phase and −

20 volts for the negative phase, in response to finding the ventricular rate for the person is below the predetermined level; and

wherein the series of pacing pulses is applied between a first electrode disposed subcutaneously as part of the subcutaneous lead assembly, and a second electrode disposed on the canister implanted subcutaneously in the person, the lead assembly being coupled to the canister;

wherein the canister is disposed at the left posterior axillary line and the subcutaneous lead assembly extends around the thorax with a distal end at the anterior precordial region;

wherein the implantable cardiac stimulus system uses only electrodes that do not directly contact a patient'"'"'s heart or reside in the intrathoracic blood vessels; and

wherein the predetermined level is in the range of approximately 20 to approximately 40 beats per minute.

13. The method of claim 12 wherein the subcutaneous lead is disposed in the left inframammary crease.